Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | GM-CSF | 267.0 | 57 | ||||||||
0 | GM-CSF | 283.0 | 35 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 313.5 | 46 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 294.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 303.5 | 58 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 298.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 316.0 | 68 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 318.0 | 69 | |
RA2159 | EO1428 | 1.0 | uM | 1 | GM-CSF | 304.0 | 63 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | GM-CSF | 311.5 | 58 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 397.0 | 50 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 356.0 | 46 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 350.0 | 49 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 296.0 | 47 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | GM-CSF | 273.0 | 53 | |
N2586 | EO1428 | 1.0 | uM | 1 | GM-CSF | 403.0 | 31 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 341.0 | 73 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 288.5 | 56 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 269.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 344.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 332.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 267.0 | 50 | |
RA2159 | PI103 | 0.1 | uM | 1 | GM-CSF | 218.0 | 75 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 324.5 | 58 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 316.0 | 75 |